肺移植患者慢性肺移植物功能障碍发生时CT可预测限制性表型进展与生存
本研究回顾52例肺移植患者慢性肺移植物功能障碍发生时的CT,比较 later 发生限制性表型(TLC≤80%)与未发生者的CT特征。结果显示 later 限制性表型组更多见实变(57% vs 4%)和磨玻璃影(71% vs 7%),炎症CT评分更高(3.4 vs 0.6),高评分(>2)者生存期更短(443天 vs 2415天)。
要点
- CLAD发生时CT出现实变或磨玻璃影提示 later 限制性表型风险高。
- 炎症CT评分>2者生存期显著短于≤2者(443天 vs 2415天)。
- 建议将CT纳入CLAD诊断时的检查流程。
核心结论
- CLAD发生时CT表现可区分 later 是否发生限制性表型,并预测生存。
研究设计与样本
- 回顾性分析52例肺移植患者CLAD发生时的CT,按 later 是否发生限制性CLAD(TLC≤80%)分组比较CT特征。
关键影像表现/征象
- later 限制性CLAD组实变出现率57%,无限制性表型组4%(p<0.001)。
- later 限制性CLAD组磨玻璃影出现率71%,无限制性表型组7%(p<0.001)。
- later 限制性CLAD组炎症CT评分3.4,无限制性表型组0.6(p<0.001)。
诊断标准与关键数值
- 炎症CT评分包含胸腔积液、中心及外周磨玻璃影和实变。
- 限制性CLAD定义为TLC≤80%。
- 炎症CT评分>2为高评分,≤2为低评分。
临床应用与阅片要点
- CLAD诊断时行CT检查,注意评估实变、磨玻璃影、胸腔积液等炎症征象并计算炎症CT评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To describe early signs for restrictive subtype of chronic lung allograft dysfunction (CLAD) after lung transplantation in computed tomography (CT) and to evaluate the predictive value for disease progression and survival.
MATERIAL AND METHODS: 52 CT examinations in lung transplant patients at CLAD onset were scored for CT features referring to airways disease, parenchymal or pleural abnormality. Patients with and without later development of restrictive CLAD (TLC≤80%) were compared. A radiological score for inflammation including pleural effusion, central and peripheral ground glass opacities and consolidations was calculated and used for survival analysis.
RESULTS: CT of patients with later development of restrictive CLAD showed significantly more often abnormalities at CLAD onset, in particular consolidations (57% vs. 4%; p<0.001) and ground glass attenuations (71% vs. 7%; p<0.001) than those of patients without the restrictive phenotype. CT score for inflammation was significantly higher in patients with than without later restrictive CLAD (3.4 vs. 0.6; p<0.001). Survival of patients with a high score (>2) for inflammation in CT at CLAD onset was significantly lower than of those with a low score (443 vs. 2415 days; p=0.019).
CONCLUSIONS: CT at CLAD onset differs in patients with/without later development of the restrictive phenotype. It is therefore an indicator for future development of restrictive CLAD and predictor for survival. It should be implemented in the diagnostic work-up at diagnosis of CLAD.
引用
- Dettmer S, Shin HO, Vogel-Claussen J, et al. CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival. Eur J Radiol. 2017. PMID: 28647206. doi:10.1016/j.ejrad.2017.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。